Your browser doesn't support javascript.
loading
Multidisciplinary consensus on the therapeutic recommendations for iatrogenic hyperprolactinemia secondary to antipsychotics.
Montejo, Ángel L; Arango, Celso; Bernardo, Miquel; Carrasco, José L; Crespo-Facorro, Benidicto; Cruz, Juan J; Del Pino-Montes, Javier; García-Escudero, Miguel A; García-Rizo, Clemente; González-Pinto, Ana; Hernández, Ana I; Martín-Carrasco, Manuel; Mayoral-Cleries, Fermín; Mayoral-van Son, Jaqueline; Mories, M Teresa; Pachiarotti, Isabella; Pérez, Jesús; Ros, Salvador; Vieta, Eduard.
Afiliação
  • Montejo ÁL; Neurosciences Area, Instituto de Biomedicina de Salamanca (IBSAL), University of Salamanca, Psychiatry Department, University Hospital of Salamanca, Salamanca, Spain. Electronic address: amontejo@usal.es.
  • Arango C; Department of Child and Adolescent Psychiatry, Hospital General Universitario Gregorio Marañón, Centro de Investigación Biomédica en Red de Salud Mental (CIBERSAM), IiSGM, School of Medicine, Universidad Complutense de Madrid, Madrid, Spain.
  • Bernardo M; Barcelona Clínic Schizophrenia Unit, Neuroscience Institute, Hospital Clínic of Barcelona, Barcelona, Institut d'Investigacions Biomèdiques August Pi i Sunyer (IDIBAPS), University of Barcelona, Centro de Investigación Biomédica en Red de Salud Mental (CIBERSAM), Barcelona, Spain.
  • Carrasco JL; Instituto de Investigación Sanitaria, Hospital Clínico San Carlos, Centro de Investigación Biomédica en Red de Salud Mental (CIBERSAM), Madrid, Spain.
  • Crespo-Facorro B; Department of Medicine & Psychiatry, University Hospital Marqués de Valdecilla, IDIVAL, Centro de Investigación Biomédica en Red de Salud Mental (CIBERSAM), Santander, Spain.
  • Cruz JJ; Department of Medical Oncology, Instituto de Biomedicina de Salamanca (IBSAL), University of Salamanca, University Hospital of Salamanca, Salamanca, Spain.
  • Del Pino-Montes J; Internal Medicine Department, University Hospital of Salamanca, Salamanca, Spain.
  • García-Escudero MA; Psychiatry Hospitalization Unit, Hospital General y Universitario de Elche, Elche, Spain.
  • García-Rizo C; Barcelona Clínic Schizophrenia Unit, Neuroscience Institute, Hospital Clínic of Barcelona, Barcelona, Institut d'Investigacions Biomèdiques August Pi i Sunyer (IDIBAPS), University of Barcelona, Centro de Investigación Biomédica en Red de Salud Mental (CIBERSAM), Barcelona, Spain.
  • González-Pinto A; International Mood Disorders Research Centre, Centro de Investigación Biomédica en Red de Salud Mental (CIBERSAM), Hospital Santiago Apóstol, University of the Basque Country, Vitoria, Spain.
  • Hernández AI; FEA Psiquiatría, Red de Salud Mental de Guipúzcoa, San Sebastián, Spain.
  • Martín-Carrasco M; Institute of Psychiatric Research, Mª Josefa Recio Foundation, Bilbao, Spain; Psychiatry Clinic Padre Menni, Centro de Investigación Biomédica en Red de Salud Mental (CIBERSAM), Pamplona, Spain.
  • Mayoral-Cleries F; University Regional Hospital of Malaga, Biomedical Research Institute (IBIMA), Malaga, Spain.
  • Mayoral-van Son J; Sierrallana Hospital, Torrelavega, Cantabria, Spain.
  • Mories MT; Endocrinology and Nutrition Department, University Hospital of Salamanca, Salamanca, Spain.
  • Pachiarotti I; Bipolar Disorders Program, Psychiatry Department, Hospital Clinic, University of Barcelona, IDIBAPS, Centro de Investigación Biomédica en Red de Salud Mental (CIBERSAM), Barcelona, Spain.
  • Pérez J; Department of Psychiatry, University of Cambridge, Cambridge, United Kingdom.
  • Ros S; International Institute of Applied Neurosciences, Barcelona, Spain.
  • Vieta E; Bipolar Disorders Program, Psychiatry Department, Hospital Clinic, University of Barcelona, IDIBAPS, Centro de Investigación Biomédica en Red de Salud Mental (CIBERSAM), Barcelona, Spain.
Front Neuroendocrinol ; 45: 25-34, 2017 04.
Article em En | MEDLINE | ID: mdl-28235557
Assuntos
Palavras-chave
Texto completo
Adicionar na Minha BVS
Imprimir
XML
PubMed Links
Buscar no Google

Texto completo: 1 Coleções: 01-internacional Base de dados: MEDLINE Assunto principal: Antipsicóticos / Hiperprolactinemia / Aripiprazol / Transtornos Mentais Tipo de estudo: Diagnostic_studies / Guideline Limite: Humans Idioma: En Revista: Front Neuroendocrinol Ano de publicação: 2017 Tipo de documento: Article País de publicação: Estados Unidos
Texto completo
Adicionar na Minha BVS
Imprimir
XML
PubMed Links
Buscar no Google

Texto completo: 1 Coleções: 01-internacional Base de dados: MEDLINE Assunto principal: Antipsicóticos / Hiperprolactinemia / Aripiprazol / Transtornos Mentais Tipo de estudo: Diagnostic_studies / Guideline Limite: Humans Idioma: En Revista: Front Neuroendocrinol Ano de publicação: 2017 Tipo de documento: Article País de publicação: Estados Unidos